Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06469398 · ClinicalTrials.gov registry record · NA
A Post Market Device Study for the Treatment of Acne
A NA study of Acne Vulgaris, sponsored by Cutera.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 3
- Study locations
NCT06469398 is a NA study of Acne Vulgaris that is active but no longer recruiting, run by Cutera. The registered enrollment target is 50 participants, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06469398, a NA study of Acne Vulgaris, is active but no longer recruiting, sponsored by Cutera.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 3
- Study locations
Study Summary
To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.
Conditions Studied
Interventions
- DEVICE Cutera Laser System
Study Locations (3)
Florida
- Dermatology of Boca - Boca Raton
New Jersey
- Schweiger Dermatology PC, Reseach Division - Hackensack
Texas
- Bellaire Dermatology Associates - Bellaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-07-21 |
| Est. Completion | 2025-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06469398
The ClinicalTrials.gov registry entry for NCT06469398 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 275-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (82% lower). The listed sponsor is Cutera, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Cutera Laser System is the first listed.
NCT06469398 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, New Jersey, Texas.
Frequently Asked Questions
What is clinical trial NCT06469398 about?
NCT06469398 is a clinical study titled "A Post Market Device Study for the Treatment of Acne". To evaluate the safety and efficacy of the Cutera laser system for the treatment of acne vulgaris.
What is the current status of trial NCT06469398?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-07-21. Estimated completion is 2025-08-18.
What conditions does trial NCT06469398 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT06469398?
The interventions under investigation include: Cutera Laser System (DEVICE).
Who is sponsoring clinical trial NCT06469398?
This trial is sponsored by Cutera, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06469398 being conducted?
This trial has 3 study locations across Florida, New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Laser Treatment of Moderate to Severe Acne Vulgaris
ACTIVE NOT RECRUITING · NA
-
A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin
COMPLETED · NA
-
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone
COMPLETED · NA
-
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris
COMPLETED · NA
-
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
COMPLETED · NA
-
A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.